Pediatrix Medical Group, Inc. (NYSE:MD) Sees Large Increase in Short Interest

Pediatrix Medical Group, Inc. (NYSE:MD) was the recipient of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 1,740,000 shares, a growth of 25.2% from the May 15th total of 1,390,000 shares. Based on an average trading volume of 873,400 shares, the short-interest ratio is presently 2.0 days. Currently, 2.1% of the shares of the company are sold short.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on MD shares. Macquarie lifted their price objective on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an “outperform” rating in a research report on Thursday, May 8th. Truist Financial lowered their target price on Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating for the company in a research note on Friday, April 11th. Finally, UBS Group cut their price target on Pediatrix Medical Group from $18.50 to $16.00 and set a “neutral” rating for the company in a report on Monday, May 12th. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, Pediatrix Medical Group currently has an average rating of “Hold” and a consensus target price of $16.67.

Pediatrix Medical Group Stock Down 0.3%

Pediatrix Medical Group stock opened at $13.37 on Friday. The company’s 50-day moving average price is $13.67 and its two-hundred day moving average price is $13.95. The company has a quick ratio of 1.81, a current ratio of 1.81 and a debt-to-equity ratio of 0.75. The stock has a market cap of $1.15 billion, a P/E ratio of -13.23, a P/E/G ratio of 0.93 and a beta of 1.27. Pediatrix Medical Group has a twelve month low of $6.62 and a twelve month high of $17.67.

Pediatrix Medical Group (NYSE:MD) last announced its earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.25 by $0.08. The company had revenue of $458.36 million during the quarter, compared to analysts’ expectations of $451.44 million. Pediatrix Medical Group had a negative net margin of 4.17% and a positive return on equity of 17.43%. Pediatrix Medical Group’s quarterly revenue was down 7.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.20 earnings per share. As a group, analysts expect that Pediatrix Medical Group will post 1.38 EPS for the current year.

Institutional Trading of Pediatrix Medical Group

Several large investors have recently modified their holdings of the stock. XTX Topco Ltd bought a new position in Pediatrix Medical Group in the 4th quarter valued at about $169,000. Principal Financial Group Inc. raised its holdings in shares of Pediatrix Medical Group by 7.5% during the 4th quarter. Principal Financial Group Inc. now owns 551,924 shares of the company’s stock worth $7,241,000 after buying an additional 38,306 shares in the last quarter. Deutsche Bank AG lifted its position in shares of Pediatrix Medical Group by 53.1% during the 4th quarter. Deutsche Bank AG now owns 74,023 shares of the company’s stock worth $971,000 after buying an additional 25,663 shares during the last quarter. Smartleaf Asset Management LLC boosted its stake in Pediatrix Medical Group by 750.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company’s stock valued at $91,000 after buying an additional 6,090 shares in the last quarter. Finally, New York State Teachers Retirement System boosted its stake in Pediatrix Medical Group by 3.3% in the fourth quarter. New York State Teachers Retirement System now owns 130,786 shares of the company’s stock valued at $1,716,000 after buying an additional 4,212 shares in the last quarter. 97.71% of the stock is owned by institutional investors and hedge funds.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.